Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for SUPN

Stock NameSupernus Pharmaceuticals Inc
TickerSUPN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS8684591089
LEI549300GRM36VBKISYJ58

Show aggregate SUPN holdings

News associated with SUPN

Contrasting Supernus Pharmaceuticals (NASDAQ:SUPN) and Evoke Pharma (NASDAQ:EVOK)
Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) and Evoke Pharma (NASDAQ:EVOK – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Volatility & Risk Supernus Pharmaceuticals has a beta […] - 2025-09-04 02:30:48
Supernus Pharmaceuticals (NASDAQ:SUPN) Raised to “Hold” at Zacks Research
Zacks Research upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a strong sell rating to a hold rating in a research report sent to investors on Tuesday morning,Zacks.com reports. Several other analysts also recently weighed in on SUPN. Cantor Fitzgerald boosted their target price on Supernus Pharmaceuticals from $42.00 to $46.00 and gave […] - 2025-08-22 03:08:51
Maryland State Retirement & Pension System Trims Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Maryland State Retirement & Pension System lessened its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 13.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 16,094 shares of the specialty pharmaceutical company’s stock after selling 2,514 shares during […] - 2025-08-15 04:51:00
Supernus Pharmaceuticals (NASDAQ:SUPN) Reaches New 1-Year High on Analyst Upgrade
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report)’s share price hit a new 52-week high on Wednesday after Cantor Fitzgerald raised their price target on the stock from $42.00 to $46.00. Cantor Fitzgerald currently has an overweight rating on the stock. Supernus Pharmaceuticals traded as high as $41.51 and last traded at $42.29, with a […] - 2025-08-08 02:19:00
SUPN Crosses Above Average Analyst Target
In recent trading, shares of Supernus Pharmaceuticals Inc (Symbol: SUPN) have crossed above the average analyst 12-month target price of $40.20, changing hands for $42.44/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down - 2025-08-07 12:32:22
Supernus Pharmaceuticals (NASDAQ:SUPN) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a research note released on Saturday morning. Separately, Cantor Fitzgerald raised shares of Supernus Pharmaceuticals from a “neutral” rating to an “overweight” rating and set a $42.00 price objective for the company in a […] - 2025-08-05 02:56:51
Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Rating Lowered by Wall Street Zen
Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Sunday. Supernus Pharmaceuticals Stock Performance Shares of Supernus Pharmaceuticals stock opened at $33.23 on Friday. The firm has a fifty day moving average […] - 2025-07-22 02:55:51
Allspring Global Investments Holdings LLC Reduces Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Allspring Global Investments Holdings LLC lessened its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 6.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,353 shares of the specialty pharmaceutical company’s stock after selling 1,356 shares during the quarter. […] - 2025-07-10 04:34:50
Robeco Institutional Asset Management B.V. Takes Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Robeco Institutional Asset Management B.V. bought a new stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 8,151 shares of the specialty pharmaceutical company’s stock, valued at approximately $267,000. Other […] - 2025-07-03 05:08:49
Illinois Municipal Retirement Fund Has $927,000 Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Illinois Municipal Retirement Fund decreased its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 2.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,303 shares of the specialty pharmaceutical company’s stock after selling 730 shares […] - 2025-07-02 05:28:54
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Stake Boosted by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC increased its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 12.5% during the first quarter, HoldingsChannel reports. The firm owned 24,881 shares of the specialty pharmaceutical company’s stock after acquiring an additional 2,762 shares during the period. Exchange Traded Concepts LLC’s holdings in Supernus Pharmaceuticals were worth $815,000 at […] - 2025-06-20 05:21:54
Azzad Asset Management Inc. ADV Acquires New Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Azzad Asset Management Inc. ADV acquired a new stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 16,847 shares of the specialty pharmaceutical company’s stock, valued at approximately $552,000. A number of other […] - 2025-06-16 05:40:53
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by Versant Capital Management Inc
Versant Capital Management Inc grew its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 6,931.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,125 shares of the specialty pharmaceutical company’s stock after purchasing an additional […] - 2025-06-06 05:45:08
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 19,824 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 24.7% during the 4th quarter, Holdings Channel reports. The firm owned 100,020 shares of the specialty pharmaceutical company’s stock after buying an additional 19,824 shares during the period. UBS […] - 2025-06-05 05:10:54
Millennium Management LLC Sells 222,273 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Millennium Management LLC decreased its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 87.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,470 shares of the specialty pharmaceutical company’s stock after selling 222,273 shares during […] - 2025-06-05 04:25:01
Squarepoint Ops LLC Sells 475 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Squarepoint Ops LLC cut its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 2.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 20,492 shares of the specialty pharmaceutical company’s stock after selling 475 shares during the period. Squarepoint Ops LLC’s holdings in Supernus Pharmaceuticals were worth $741,000 at the end of […] - 2025-06-03 05:04:50
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 1,083 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 3.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 28,563 shares of the specialty pharmaceutical company’s stock after buying an additional 1,083 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Supernus Pharmaceuticals […] - 2025-05-26 04:47:00
Graham Capital Management L.P. Takes Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Graham Capital Management L.P. bought a new position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 6,908 shares of the specialty pharmaceutical company’s stock, valued at approximately $250,000. […] - 2025-05-19 05:26:49
Supernus Pharmaceuticals (NASDAQ:SUPN) Upgraded at StockNews.com
StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a buy rating to a strong-buy rating in a research note published on Friday. Separately, Cantor Fitzgerald reiterated a “neutral” rating and set a $36.00 price objective on shares of Supernus Pharmaceuticals in a research note on Wednesday, February 26th. Get Our Latest Stock […] - 2025-05-19 02:38:47
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Acquired by Northern Trust Corp
Northern Trust Corp boosted its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 18.3% in the fourth quarter, HoldingsChannel reports. The firm owned 717,161 shares of the specialty pharmaceutical company’s stock after purchasing an additional 110,867 shares during the quarter. Northern Trust Corp’s holdings in Supernus Pharmaceuticals were worth $25,933,000 as […] - 2025-05-12 04:49:02
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by First Trust Advisors LP
First Trust Advisors LP lessened its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 48.1% in the 4th quarter, Holdings Channel reports. The firm owned 27,019 shares of the specialty pharmaceutical company’s stock after selling 25,048 shares during the period. First Trust Advisors LP’s holdings in Supernus Pharmaceuticals were worth $977,000 […] - 2025-05-08 04:44:59
Barclays PLC Purchases 14,061 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Barclays PLC increased its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 12.9% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 122,849 shares of the specialty pharmaceutical company’s stock after buying an additional 14,061 shares during the period. Barclays PLC’s holdings in Supernus Pharmaceuticals were worth $4,442,000 at […] - 2025-04-28 04:59:03
Raymond James Financial Inc. Takes Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Raymond James Financial Inc. bought a new stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 189,364 shares of the specialty pharmaceutical company’s stock, valued at approximately $6,847,000. Raymond James Financial Inc. owned approximately […] - 2025-04-24 04:41:05
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Position Raised by Invesco Ltd.
Invesco Ltd. lifted its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 4.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 508,069 shares of the specialty pharmaceutical company’s stock after acquiring an additional 22,027 shares during the period. Invesco Ltd. owned 0.92% of […] - 2025-04-20 05:22:48
JPMorgan Chase & Co. Acquires 44,414 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
JPMorgan Chase & Co. grew its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 17.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 297,810 shares of the specialty pharmaceutical company’s stock after purchasing an additional 44,414 shares during the quarter. […] - 2025-04-15 04:32:48
Arrowstreet Capital Limited Partnership Purchases 77,393 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Arrowstreet Capital Limited Partnership increased its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 79.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 174,916 shares of the specialty pharmaceutical company’s stock after acquiring an additional 77,393 shares during […] - 2025-04-08 05:01:05
Prudential Financial Inc. Has $2.37 Million Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Prudential Financial Inc. grew its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 14.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 66,733 shares of the specialty pharmaceutical company’s stock after buying an additional 8,352 shares […] - 2025-04-04 04:37:01
Sei Investments Co. Sells 16,825 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Sei Investments Co. cut its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 5.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 296,915 shares of the specialty pharmaceutical company’s stock after selling 16,825 shares during the period. Sei Investments Co.’s holdings in Supernus Pharmaceuticals were worth $10,736,000 at the end of […] - 2025-03-30 05:37:02
Swiss National Bank Has $3.92 Million Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Swiss National Bank lifted its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 0.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 108,400 shares of the specialty pharmaceutical company’s stock after purchasing an additional 800 shares during the quarter. […] - 2025-03-26 05:44:46
Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Rating Lowered by StockNews.com
Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) was downgraded by StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Monday. Separately, Cantor Fitzgerald reiterated a “neutral” rating and issued a $36.00 price objective on shares of Supernus Pharmaceuticals in a research note on Wednesday, February 26th. Get Our Latest […] - 2025-03-26 03:58:55

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) SUPN holdings

DateNumber of SUPN Shares HeldBase Market Value of SUPN SharesLocal Market Value of SUPN SharesChange in SUPN Shares HeldChange in SUPN Base ValueCurrent Price per SUPN Share HeldPrevious Price per SUPN Share Held
2025-11-11 (Tuesday)36,699USD 1,692,191SUPN holding increased by 26056USD 1,692,1910USD 26,056 USD 46.11 USD 45.4
2025-11-10 (Monday)36,699SUPN holding increased by 94USD 1,666,135SUPN holding decreased by -18427USD 1,666,13594USD -18,427 USD 45.4 USD 46.02
2025-11-07 (Friday)36,605USD 1,684,562SUPN holding decreased by -45573USD 1,684,5620USD -45,573 USD 46.02 USD 47.265
2025-11-06 (Thursday)36,605SUPN holding increased by 94USD 1,730,135SUPN holding increased by 10102USD 1,730,13594USD 10,102 USD 47.265 USD 47.11
2025-11-05 (Wednesday)36,511USD 1,720,033SUPN holding decreased by -361094USD 1,720,0330USD -361,094 USD 47.11 USD 57
2025-11-04 (Tuesday)36,511SUPN holding increased by 94USD 2,081,127SUPN holding increased by 52700USD 2,081,12794USD 52,700 USD 57 USD 55.7
2025-11-03 (Monday)36,417USD 2,028,427SUPN holding increased by 20758USD 2,028,4270USD 20,758 USD 55.7 USD 55.13
2025-10-31 (Friday)36,417USD 2,007,669SUPN holding decreased by -49892USD 2,007,6690USD -49,892 USD 55.13 USD 56.5
2025-10-30 (Thursday)36,417SUPN holding increased by 470USD 2,057,561SUPN holding increased by 56032USD 2,057,561470USD 56,032 USD 56.5 USD 55.68
2025-10-29 (Wednesday)35,947SUPN holding increased by 188USD 2,001,529SUPN holding increased by 100223USD 2,001,529188USD 100,223 USD 55.68 USD 53.17
2025-10-28 (Tuesday)35,759USD 1,901,306SUPN holding increased by 16092USD 1,901,3060USD 16,092 USD 53.17 USD 52.72
2025-10-27 (Monday)35,759USD 1,885,214SUPN holding decreased by -3934USD 1,885,2140USD -3,934 USD 52.72 USD 52.83
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SUPN by Blackrock for IE00BYXG2H39

Show aggregate share trades of SUPN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY94 45.400* 36.53
2025-11-06BUY94 47.265* 36.42
2025-11-04BUY94 57.000* 36.26
2025-10-30BUY47057.65055.170 55.418USD 26,046 35.95
2025-10-29BUY18855.68055.945 55.918USD 10,513 35.85
2025-10-22SELL-37650.67051.470 51.390USD -19,323 35.41 Loss of -6,010 on sale
2025-10-20BUY18851.59052.150 52.094USD 9,794 35.23
2025-10-17BUY47050.17050.850 50.782USD 23,868 35.15
2025-10-15BUY75249.27049.670 49.630USD 37,322 35.07
2025-10-03BUY64448.35049.660 49.529USD 31,897 34.92
2025-10-02BUY9247.96048.640 48.572USD 4,469 34.85
2025-09-30BUY18447.79048.440 48.375USD 8,901 34.70
2025-09-26BUY18447.03048.000 47.903USD 8,814 34.55
2025-09-25BUY18447.18047.520 47.486USD 8,737 34.48
2025-09-24SELL-1,61147.10047.170 47.163USD -75,980 34.41 Loss of -20,548 on sale
2025-09-18BUY9746.13046.240 46.229USD 4,484 34.34
2025-09-17BUY29144.80045.160 45.124USD 13,131 34.28
2025-08-20SELL-38842.68042.960 42.932USD -16,658 34.05 Loss of -3,446 on sale
2025-07-30BUY38833.56034.610 34.505USD 13,388 33.85
2025-07-17SELL-19433.59034.400 34.319USD -6,658 33.89 Loss of -83 on sale
2025-07-11SELL-77633.12033.370 33.345USD -25,876 33.90 Profit of 431 on sale
2025-07-07BUY29131.45032.120 32.053USD 9,327 33.94
2025-07-02BUY5,33532.07032.220 32.205USD 171,814 33.97
2025-06-20BUY81932.28033.300 33.198USD 27,189 33.98
2025-06-13BUY83232.03032.910 32.822USD 27,308 34.04
2025-06-11BUY18433.15033.660 33.609USD 6,184 34.05
2025-06-10BUY18433.26033.700 33.656USD 6,193 34.06
2025-06-04SELL-9232.30032.410 32.399USD -2,981 34.10 Profit of 156 on sale
2025-04-23BUY9230.84031.640 31.560USD 2,904 34.69
2025-04-10SELL-72831.07031.550 31.502USD -22,933 35.06 Profit of 2,590 on sale
2025-04-08SELL-9130.64033.140 32.890USD -2,993 35.15 Profit of 205 on sale
2025-04-07SELL-9132.27034.260 34.061USD -3,100 35.18 Profit of 102 on sale
2025-04-04SELL-46032.74033.350 33.289USD -15,313 35.21 Profit of 884 on sale
2025-04-01BUY38031.68032.660 32.562USD 12,374 35.28
2025-03-31SELL-27632.75032.870 32.858USD -9,069 35.31 Profit of 677 on sale
2025-03-21BUY1,47632.15032.900 32.825USD 48,450 35.54
2025-03-14SELL-1,39231.26031.570 31.539USD -43,902 35.78 Profit of 5,908 on sale
2025-03-07SELL-17432.07032.300 32.277USD -5,616 36.08 Profit of 661 on sale
2025-03-04SELL-8731.65031.980 31.947USD -2,779 36.28 Profit of 377 on sale
2025-02-25BUY17432.81033.500 33.431USD 5,817 36.64
2025-02-19SELL-8733.52035.360 35.176USD -3,060 36.88 Profit of 148 on sale
2025-02-13BUY26139.53039.540 39.539USD 10,320 36.68
2025-02-12BUY8738.99039.490 39.440USD 3,431 36.63
2025-02-11BUY34838.65038.660 38.659USD 13,453 36.59
2024-12-30SELL-3,23336.91037.280 37.243USD -120,407 35.73 Loss of -4,876 on sale
2024-11-18SELL-1,42535.25036.200 36.105USD -51,450 34.90 Loss of -1,713 on sale
2024-11-08SELL-9536.60036.780 36.762USD -3,492 34.57 Loss of -208 on sale
2024-10-21SELL-9633.67034.530 34.444USD -3,307 0.00 Loss of -3,307 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SUPN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19122,1513301,18840.6%
2025-09-18121,7610267,52545.5%
2025-09-1770,393750204,21134.5%
2025-09-1692,8030275,02433.7%
2025-09-15117,876210292,58040.3%
2025-09-1256,904200164,68934.6%
2025-09-1180,78550192,70641.9%
2025-09-1097,2060247,18239.3%
2025-09-09103,40321,544214,67548.2%
2025-09-0894,0301,712217,57143.2%
2025-09-0565,260300193,61133.7%
2025-09-0487,4799,555199,60343.8%
2025-09-0371,5531,695171,33341.8%
2025-09-02151,60032,060318,69847.6%
2025-08-2978,3442,289147,46753.1%
2025-08-2896,124974162,32859.2%
2025-08-2798,4244,105244,87540.2%
2025-08-2668,3820134,61050.8%
2025-08-25114,0932,502258,41544.2%
2025-08-22170,4587,565320,38553.2%
2025-08-21126,8771,383256,89649.4%
2025-08-2097,552696267,86636.4%
2025-08-1996,5005,963208,44446.3%
2025-08-18104,7711,006285,51036.7%
2025-08-15124,03620,531334,97737.0%
2025-08-1483,0364,471360,72523.0%
2025-08-13143,7964,486408,81035.2%
2025-08-12120,422909359,23133.5%
2025-08-11112,8106,919330,27234.2%
2025-08-08228,44958,762395,64057.7%
2025-08-07334,0140923,64436.2%
2025-08-06692,0716,1101,667,36241.5%
2025-08-05248,6500476,50952.2%
2025-08-04162,9890229,99770.9%
2025-08-01250,1790326,68476.6%
2025-07-31433,277375912,33647.5%
2025-07-30158,3605215,82673.4%
2025-07-29188,5610455,53841.4%
2025-07-28160,9300241,81666.6%
2025-07-2598,8530302,32832.7%
2025-07-24122,0570194,07162.9%
2025-07-2362,1900125,50949.6%
2025-07-22141,5161,325343,16241.2%
2025-07-21197,0890471,96241.8%
2025-07-18105,7060300,27935.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.